(Q39077654)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

8 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN. (English)

1 reference

8 September 2017

1 reference

Lei Shen

1

1 reference

PubMed ID

24132591

8 September 2017

Xiao-Dong Chen

series ordinal

2

1 reference

PubMed ID

24132591

8 September 2017

Yao-Hui Zhang

series ordinal

3

1 reference

8 September 2017

15 October 2013

1 reference

8 September 2017

1 reference

8 September 2017

35

1 reference

8 September 2017

3

1 reference

8 September 2017

2069-2074

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-1274-1

8 September 2017

0 references

cites work

Adult-specific functions of animal microRNAs

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

Diversifying microRNA sequence and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

MicroRNA regulation by RNA-binding proteins and its implications for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

CCN1/CYR61: the very model of a modern matricellular protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

CYR61 controls p53 and NF-κB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

Expression and regulation of Cyr61 in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

CCN1: a novel target for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1274-1

The miRNAs in the pathgenesis of osteosarcoma

21 January 2018

1 reference

12 December 2020

miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma

1 reference

12 December 2020

Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy

1 reference

12 December 2020

Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia

1 reference

12 December 2020

Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.

1 reference

12 December 2020

Involvement of Cyr61 in the growth, invasiveness and adhesion of esophageal squamous cell carcinoma cells

1 reference

12 December 2020

Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer

1 reference

12 December 2020

T lymphocyte trafficking: molecules and mechanisms

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S13277-013-1274-1

Identifiers

DOI

10.1007/S13277-013-1274-1

1 reference

8 September 2017

1 reference

PubMed ID

24132591